Press Release Alzheimer’s Association Statement On Gantenerumab Phase 3 Topline Data Release Read Press Release
Press Release Alzheimer’s Impact Movement Names Dr. Joanne Pike its Next President and Chief Executive Officer Read Press Release
Press Release Alzheimer’s Association Statement on Lecanemab Phase 3 Topline Data Release Read Press Release
